Vortioxetine

CHEMBL2104993 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

298.4 g/mol

LogP

4.2

Phase

4

This multimodal antidepressant is used to treat major depressive disorder and works by both blocking serotonin reuptake and modulating multiple serotonin receptor subtypes, which may offer benefits for mood and cognitive function. Unlike some antidepressants, it may improve concentration and memory alongside mood. Sexual side effects are generally less common than with typical SSRIs.

Peso Molecular

298,4000 g/mol

LogP

4,20

TPSA

40,60 Å²

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Cardiovascular Disease Non-Small Cell Lung Cancer Schizophrenia Bipolar Disorder Generalized Anxiety Disorder Type 2 Diabetes Major Depressive Disorder Breast Cancer Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1

InChI

InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3

Molecular Formula

C18H22N2S

HBD / HBA

1 / 3

Ligações Rotacionáveis

3

Átomos Pesados

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This multimodal antidepressant is used to treat major depressive disorder and works by both blocking serotonin reuptake and modulating multiple serotonin receptor subtypes, which may offer benefits for mood and cognitive function. Unlike some antidepressants, it may improve concentration and memory alongside mood. Sexual side effects are generally less common than with typical SSRIs.

Yes, Vortioxetine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2104993. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 9966051. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Procura informações acessíveis para o paciente?

Vortioxetine no PillFYI

Estrutura

Dados Rápidos

Fórmula: C18H22N2S
Sinônimos: 1

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.